Anaptysbio (ANAB) Other Operating Expenses (2023)

Anaptysbio (ANAB) has 1 years of Other Operating Expenses data on file, last reported at $7.3 million in Q4 2023.

• Quarterly Other Operating Expenses changed N/A year-over-year to $7.3 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $7.3 million (changed N/A YoY) and the FY2023 annual result came in at $7.3 million, changed N/A from the prior year.
• Other Operating Expenses held at $7.3 million in Q4 2023.
• In the past five years, Other Operating Expenses ranged from a high of $7.3 million in Q4 2023 to a low of $7.3 million in Q4 2023.